Evidence map›Paper›PMID 30401974›Full record

ArticleScientific reports2018

An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy.

Suguru Koyama, Brian W LeBlanc, Kelsey A Smith, Catherine Roach, Joshua Levitt, Muhammad M Edhi, Mai Michishita, Takayuki Komatsu, Okishi Mashita, Aki Tanikawa and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Effects of FeArchives of Razi Institute · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Suguru KoyamaDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA.
Brian W LeBlancDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA.
Kelsey A SmithDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA.
Catherine RoachDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA.
Joshua LevittDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA.
Muhammad M EdhiDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA.
Mai MichishitaLaboratory for Pharmacology, Asahi KASEI Pharma Corporation, Shizuoka, Japan.
Takayuki KomatsuLaboratory for Pharmacology, Asahi KASEI Pharma Corporation, Shizuoka, Japan.
Okishi MashitaLaboratory for Safety Assessment & ADME, Asahi KASEI Pharma Corporation, Shizuoka, Japan.
Aki TanikawaLaboratory for Safety Assessment & ADME, Asahi KASEI Pharma Corporation, Shizuoka, Japan.
Satoru YoshikawaLaboratory for Pharmacology, Asahi KASEI Pharma Corporation, Shizuoka, Japan.
Carl Y SaabDepartment of Neurosurgery, Rhode Island Hospital, Providence, RI, USA. carl_saab@brown.edu.
Asahi Kasei (Japan) · JPBrown University · USRhode Island Hospital · USProvidence College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a multimodal method combining quantitative electroencephalography (EEG), behavior and pharmacology for pre-clinical screening of analgesic efficacy in vivo. The method consists of an objective and non-invasive approach for realtime assessment of spontaneous nociceptive states based on EEG recordings of theta power over primary somatosensory cortex in awake rats. Three drugs were chosen: (1) pregabalin, a CNS-acting calcium channel inhibitor; (2) EMA 401, a PNS-acting angiotensin II type 2 receptor inhibitor; and (3) minocycline, a CNS-acting glial inhibitor. Optimal doses were determined based on pharmacokinetic studies and/or published data. The effects of these drugs at single or multiple doses were tested on the attenuation of theta power and paw withdrawal latency (PWL) in a rat model of neuropathic pain. We report mostly parallel trends in the reversal of theta power and PWL in response to administration of pregabalin and EMA 401, but not minocycline. We also note divergent trends at non-optimal doses and following prolonged drug administration, suggesting that EEG theta power can be used to detect false positive and false negative outcomes of the withdrawal reflex behavior, and yielding novel insights into the analgesic effects of these drugs on spontaneous nociceptive states in rats.

Indexed as

Biological AssayElectroencephalographyAnalgesicsAnimalsBehavior, AnimalDrug Evaluation, PreclinicalMaleNociceptionPain ThresholdRatsRats, Sprague-DawleySomatosensory CortexAnalgesics

Identifiers

PMID30401974
PMCPMC6219560
OpenAlexW2898827376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.